HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsuyoshi Kitajima Selected Research

Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)

8/2009Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tsuyoshi Kitajima Research Topics

Disease

33Schizophrenia (Dementia Praecox)
01/2012 - 11/2004
16Major Depressive Disorder (Major Depressive Disorders)
12/2012 - 01/2006
11Bipolar Disorder (Manic Depressive Psychosis)
01/2021 - 06/2009
10Psychotic Disorders (Schizoaffective Disorder)
10/2011 - 06/2008
7Mood Disorders (Mood Disorder)
12/2012 - 12/2008
6Mental Disorders (Mental Disorder)
10/2012 - 03/2010
5Sleep Initiation and Maintenance Disorders (Insomnia)
01/2021 - 06/2002
2Headache (Headaches)
01/2019 - 06/2009
2REM Sleep Behavior Disorder
01/2016 - 01/2016
1Sleep Wake Disorders
01/2021
1Dizziness (Lightheadedness)
01/2019
1Mania (Manias)
01/2019
1Sleepiness
01/2019
1Snoring
06/2009
1Apnea
06/2009
1Disorders of Excessive Somnolence (Hypersomnia)
06/2009
1Hypertension (High Blood Pressure)
06/2009
1Cognitive Dysfunction
10/2008
1Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome)
10/2004
1Sleep Deprivation
12/2003
1Alzheimer Disease (Alzheimer's Disease)
06/2002

Drug/Important Bio-Agent (IBA)

11Methamphetamine (Desoxyn)FDA LinkGeneric
10/2011 - 02/2006
9Serotonin (5 Hydroxytryptamine)IBA
12/2012 - 04/2006
5Fluvoxamine (Luvox)FDA LinkGeneric
01/2010 - 01/2006
4serotonin 6 receptorIBA
01/2012 - 07/2010
4Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
09/2011 - 01/2009
3Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
03/2011 - 01/2009
3Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2011 - 01/2009
3Glutamic Acid (Glutamate)FDA Link
03/2011 - 08/2009
35-HT1A Serotonin ReceptorIBA
01/2011 - 11/2009
3Antipsychotic Agents (Antipsychotics)IBA
06/2010 - 10/2008
2GABA-A Receptors (GABA(A) Receptor)IBA
01/2021 - 09/2005
2ramelteon (Rozerem)FDA Link
01/2019 - 01/2016
2MelatoninIBA
01/2019 - 12/2012
2Sirtuin 1IBA
10/2011 - 10/2010
2Factor X (Stuart Factor)IBA
08/2011 - 03/2010
2Proteins (Proteins, Gene)FDA Link
09/2010 - 11/2004
25-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
09/2010 - 06/2009
2Risperidone (Risperdal Consta)FDA LinkGeneric
04/2010 - 10/2008
2Neuregulin-1 (Neuregulin 1)IBA
08/2009 - 04/2008
2Estrogen Receptor alphaIBA
08/2009 - 08/2009
2Glycogen Synthase Kinase 3 betaIBA
10/2008 - 04/2005
2Butyric Acid (Butanoic Acid)IBA
03/2007 - 09/2005
2Pharmaceutical PreparationsIBA
06/2002 - 06/2002
1Psychotropic Drugs (Psychoactive Drugs)IBA
01/2021
1Melatonin Receptors (Melatonin Receptor)IBA
01/2019
1Clonazepam (Rivotril)FDA LinkGeneric
01/2016
1CatecholaminesIBA
12/2012
1sapropterin (tetrahydrobiopterin)FDA Link
12/2012
1GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA
12/2012
1Casein Kinase IdeltaIBA
10/2012
1Ubiquitin-Specific ProteasesIBA
09/2011
1metabotropic glutamate receptor 3 (mGluR3)IBA
03/2011
1necdinIBA
09/2010
1Antidepressive Agents (Antidepressants)IBA
08/2010
1Opioid Analgesics (Opioids)IBA
06/2010
1Sigma-1 ReceptorIBA
06/2010
1Aripiprazole (Abilify)FDA Link
04/2010
1Olanzapine (Zyprexa)FDA Link
04/2010
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
08/2009
1Brain-Derived Neurotrophic Factor (BDNF)IBA
07/2009
1Oxygen (Dioxygen)IBA
06/2009
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
05/2009
1OxidesIBA
01/2009
1Orphan Nuclear ReceptorsIBA
01/2009
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
12/2008
1Vesicle-Associated Membrane Protein 2 (VAMP2)IBA
10/2008
1Neurotransmitter Agents (Neurotransmitter)IBA
10/2008
1SNARE Proteins (SNAREs)IBA
10/2008
1Synaptosomal-Associated Protein 25IBA
10/2008
1Dopamine (Intropin)FDA LinkGeneric
10/2008
1Therapeutic UsesIBA
10/2008
1Cholinergic Agents (Cholinergics)IBA
10/2008
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
10/2008
1EnzymesIBA
10/2008
1NicotineFDA Link
10/2008
1Glutathione (Reduced Glutathione)IBA
10/2008
1Serotonin ReceptorsIBA
10/2008
1Glutamate-Cysteine LigaseIBA
10/2008
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
06/2008
1IceIBA
04/2008
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
03/2007
1Transcription Factors (Transcription Factor)IBA
12/2006
12',3'-Cyclic Nucleotide 3'-PhosphodiesteraseIBA
12/2006
1serotonin 7 receptorIBA
04/2006
1Chromogranin AIBA
04/2006
1AminesIBA
10/2005
1gamma-Aminobutyric Acid (GABA)IBA
09/2005
1Glycogen Synthase (Synthase I)IBA
04/2005
1rho GTPase-activating proteinIBA
03/2005
1Casein Kinase I (Casein Kinase 1)IBA
10/2004
1Indicators and Reagents (Reagents)IBA
12/2003
1yokukansankachimpihangeIBA
06/2002
1Donepezil (Aricept)FDA LinkGeneric
06/2002

Therapy/Procedure

2Phototherapy (Light Therapy)
01/2021 - 01/2019
1Therapeutics
01/2021